2/28
07:37 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
High
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at William Blair. They set an "outperform" rating on the stock.
2/27
05:49 pm
gpcr
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights [Yahoo! Finance]
Medium
Report
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights [Yahoo! Finance]
2/27
04:05 pm
gpcr
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights
Medium
Report
Structure Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Highlights
1/30
09:34 am
gpcr
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences [Yahoo! Finance]
Low
Report
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences [Yahoo! Finance]
1/30
08:30 am
gpcr
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
Low
Report
Structure Therapeutics to Participate in Multiple Upcoming Healthcare Investor Conferences
1/8
07:54 am
gpcr
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $50.00 price target on the stock.
Medium
Report
Structure Therapeutics Inc. (NASDAQ: GPCR) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $50.00 price target on the stock.